Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$307,394,688
-$80,248,124 QoQ
Shares Held
1,621,109
-17.5% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#77
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names. AZN ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,394,688 | 1,621,109 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $387,642,812 | 1,965,535 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||